A method combining field asymmetric waveform ion mobility spectrometry with liquid chromatography-mass spectrometry (LC-FAIMS-MS) has been developed for the analysis of the oxypurine compounds hypoxanthine (HX) and xanthine (XA) in saliva. Separation of the oxypurines from interfering matrix components was investigated using FAIMS-MS. The selected FAIMS parameters were then applied to the rapid LC-FAIMS-MS analysis of HX and XA using a short chromatographic separation method (7 min). A comparison of the LC-MS method with and without FAIMS applied, resulted in improved discrimination from saliva matrix interferences and improved chromatographic peak integration for both HX and XA using a FAIMS separation. A quantitative evaluation of the LC-FAIMS-MS method was performed giving limits of detection of 2.0 ng mL −1 for HX and 1.8 ng mL −1 for XA, and limits of quantification of 6.6 ng mL −1 for HX and 6.0 ng mL −1 for XA.
Introduction
Exhaustive exercise and overtraining can have major health implications for athletes, and exercise induced oxidative stress and inflammation can be associated with many known diseases [17, 34] . The identification of biomarkers of oxidative stress could therefore lead to the early identification and effective treatment of diseases and chronic inflammation [25] . Exercise induced muscle fatigue or muscular stress has previously been related to oxidative stress, ATP depletion, muscle damage or immunological compromise [2, 7, 13, 20, 32] .
The oxypurine compounds hypoxanthine (HX) and xanthine (XA) are naturally occurring purine derivatives ( Fig. 1) , which are derived from the degradation of purine Electronic supplementary material The online version of this article (https://doi.org/10.1007/s12127-018-0232-4) contains supplementary material, which is available to authorized users.
nucleotides (adenine and guanine). They have been positively correlated with ATP consumption and the formation of free radicals and reactive oxygen species [12, 29] . HX is also produced by the action of xanthine oxidase on XA, or from the reduction of XA by xanthine oxidoreductase (XOR). In the purine catabolism, XOR catalyses the oxidative hydroxylation of HX to XA and subsequently of XA to uric acid (UA). UA acts as a potent antioxidant and free radical scavenger associated with oxidative stress and other diseases [15, 16, 37] . XOR therefore has important functions as a cellular defence enzyme against oxidative stress [33] . HX and XA are usually analysed in plasma, serum or urine, and it has been reported that plasma and or urinary levels of these oxypurines can changes as a result of oxidative stress [6, 27] . In a study of twenty healthy males performing exercise to exhaustion, serum HX and XA levels were found to significantly increase post exercise, leading to the proposal of oxypurines as biomarkers of oxidative stress and muscle fatigue [32] . Similar results were also observed in the analysis of HX and XA in plasma where an increase in concentrations of both HX and XA were observed post-exercise, with a peak increase in the levels of HX post exercise of nearly nine times the resting level [18] . HX has been suggested as an indicator of the effectiveness of a training regime [38] , and as a potential biomarker to normalise for metabolomic changes due to exercise, although further research is required [10, 11] .
HX and XA have been detected in plasma, serum or urine using a variety of methods including high performance liquid chromatography (HPLC) and capillary electrophoresis [15, 16, 26] . These oxypurines have also been detected in saliva [1, 15, 16, 21, 26] , which is known to change in response to a variety of different physiological states [9] . However, saliva is a complex biofluid which can require careful sample preparation and/or extended analysis times to separate HX and XA from co-eluting matrix interferences. This results in the relatively long analysis times (15-60 min) reported for the liquid chromatography-mass spectrometry (LC-MS) analysis of HX, XA and structurally related purine compounds in saliva and other biofluids [1, 14, 19, 23, 28] .
The performance of liquid chromatographic separation can be improved by the use of ultra-high performance liquid chromatography (UHPLC) and high resolution mass spectrometry (HRMS), using time-of-flight (TOF) or Orbitrap mass analysers, or by tandem MS. However, even the highest resolution mass analysers cannot separate isobaric analytes and matrix interferences. An alternative approach to enhancing the selectivity and performance of LC-MS analyses is the incorporation of a rapid gas-phase ion separation technique such as ion mobility spectrometry (IMS) in combination with LC-MS using either drift tube IMS or field asymmetric waveform ion mobility spectrometry (FAIMS), also known as differential ion mobility spectrometry. FAIMS separates ions based on differences in the mobility of ions in low and high electric fields, which is a separation mechanism that is highly orthogonal to LC and MS. The combination of a miniaturised FAIMS device with LC-MS has been shown to improve selectivity and limits of detection and quantification without loss of linear dynamic range, whilst reducing interfering chemical noise in the analysis of complex biofluids [3, 5, 30] . Here, we report the development of a rapid LC-FAIMS-MS method, requiring minimal sample pre-treatment, for the determination of the oxypurines HX and XA in saliva. The method has been applied to the analysis of saliva samples collected from male cyclists pre-and post-exhaustive exercise. 
Experimental

Saliva sample collection
Saliva samples were collected from trained male cyclists (n = 11) aged between 18 and 45. Prior to the exercise performance test, participants were asked to arrive in a euhydrated and fasted state (from 10 pm the day prior to the test) and to refrain from caffeinated and alcoholic beverages for twenty-four hours prior to the test. Ethical approval for the study was obtained from the local ethical advisory committee (Ethical Advisory Committee, Loughborough University) with reference numbers: R14-P72, G10-P24 and G10-P23. Saliva was collected from participants pre-exercise, immediately post-exercise, one-hour post-exercise and twenty-four hours post exercise. The exhaustive exercise consisted of cycling on a cycle ergometer sub maximally at 70% of their maximum power output (determined via a pre-testing session to measure maximum power output) for 45 min and then to cycle the greatest distance possible for a further 15 min. The one hour cycling exercise protocol was designed to induce oxidative stress [36] . Saliva was collected by a passive drool method where participants were asked to sit comfortably with their head tilted forward, to allow saliva to pool in the front of the mouth [8, 24] . Saliva was dribbled from the mouth into a glass collection vial (30 mL, Chromacol, UK) at regular intervals. This process was continued for at least 5-10 min to provide 1.5-2 mL of saliva. Saliva collected from all participants was realiquoted into 600 μL aliquots into microcentrifuge tubes (2 mL LoBind Eppendorf, Sigma Aldrich, UK). 600 μL from all participants was pooled together and re-aliquoted as 600 μL aliquots to be used for method development and quality control (QC). Samples were aliquoted over ice prior to storage to minimise freeze-thaw cycles and stored at −80°C to arrest biological activity.
Saliva sample pre-treatment
Saliva samples stored at −80°C were thawed at room temperature for 20 min. Each sample was vortexed for 30 s followed by centrifugation at 10,000 g for 10 min at ambient temperature. An aliquot of the supernatant (250 μL) was transferred to a fresh microcentrifuge tube and diluted with 500 μL of an internal standard solution (1-MX d3 (0.3 μg mL . The diluted supernatant was vortexed for 30 s to ensure homogeneity and transferred to an autosampler vial (2 mL) for LC-FAIMS-MS analysis.
Instrumentation
Analysis was performed using an Agilent 1200 series HPLC interfaced to an Agilent 6230 TOF mass spectrometer fitted with a modified Jet Stream electrospray ionisation (ESI) source (Agilent Technologies, Santa Clara, USA) to accommodate the FAIMS. The miniaturised chip-based ultraFAIMS device (Owlstone Medical Ltd), described in detail elsewhere [4] , was located in front of the transfer capillary of the MS behind a modified spray shield within the ESI source. The electrodes of the FAIMS chip are arranged as multiple parallel channels, with a trench length of 78.1 mm, a 100 μm electrode gap and a path length of 700 μm. Nitrogen (N 2 ) was used as the carrier gas for the FAIMS and the MS drying gas. Samples were introduced into the ESI source either by direct syringe infusion at a flow rate of 10 μL min 
HPLC conditions
Mobile phase A consisted of 0.1% aqueous formic acid (v/v) and mobile phase B was 0.1% formic acid in ACN. The mobile phase flow rate was set to 0.3 mL min −1 and the column was maintained at 40°C. Saliva samples were analysed with an injection volume of 10 μL by the chromatographic gradient programme: 5% B (0 min), increased to 8% B (0-2 min) for the retention of the oxypurine compounds, followed by a column clean-up and equilibration phase by increasing from 8% B to 95% B (2-3 min), hold (3-4 min), then returning to initial conditions of 5% B (4-5 min) and hold (5-7 min).
MS conditions
The TOF-MS was operated in positive ion mode with a scan rate of 10 scans s −1 for FAIMS-MS analysis, and at 2 scans s 
Analytical protocol for LC-FAIMS-MS salivary analysis
The sample list for analysis was randomised using Microsoft Excel. A series of five consecutive injections of a pooled saliva extract were run prior to sample analysis to condition the chromatographic column. A pooled saliva extract was analysed after every five saliva samples as a QC sample. Method blanks demonstrated no carry-over between saliva sample runs.
Data processing
Data were acquired using the FAIMS Control software in combination with the MassHunter Acquisition software. MassHunter Qualitative Analysis software version B.05.00 (Agilent Technologies, Santa Clara, USA) was used for processing raw LC-MS and LC-FAIMS-MS data. A modified prototype version of the MassHunter Qualitative Analysis software was used for processing raw FAIMS-MS data, with a mass extraction window of m/z ± 0.02. Microsoft Excel and PowerPoint 2010 (Microsoft, Seattle, USA), and OriginLab 2015 (Academic version, b9.2.272) were used to produce figures in this report.
Results and discussion
LC-FAIMS-MS method development for the analysis of HX and XA
A short chromatographic method (7 min) was developed for HX, XA and the internal standard 1-MX d3 with the analytes eluting in <2 min and the remainder of the chromatographic method used to wash-out the saliva matrix and re-equilibrate the column. The retention times for the extracted ion chromatograms (EICs) of the [ Fig. 2 (a) ), 0.95 min (Fig. 2 (b) ) and 1.62 min respectively. In the EICs for m/z 137.0458 and m/z 153.0407 from an unspiked pooled saliva extract (Fig. 2 (c) and (d)), co-eluting matrix interferences are observed, with HX ( Fig. 2 (c) ) unresolved from these interferences and XA is not baseline resolved ( Fig. 2 (d) ). Selection of optimal FAIMS conditions for the targeted analysis of HX and XA in saliva by LC-FAIMS-MS was determined by the removal of co-eluting matrix interferences to improve the signal-to-noise ratio (S:N), peak area, peak height and peak shape compared to LC-MS alone. The oxypurine compounds and the internal standard (1-MX d3 ) were first analysed as individual standard solutions along with an unspiked pooled saliva extract (post sample preparation). The samples were directly infused into the ESI source and analysed by FAIMS-MS, in order to select FAIMS DF and CF parameters to be further tested using LC-FAIMS-MS. FAIMS-MS analysis was performed by scanning the DF from 180 to 300 Td in 10 Td steps and the CF from −2 to 5 Td in 0.05 Td steps. Figure 3 (a) shows that ions from the saliva extract are observed in the CF range from −2 to 3 Td at DF 230 Td, with the highest intensity at 2 Td. The selected CF responses for HX and XA in Fig. 3 (a) are in the CF range 0 to 1.5 Td overlapping the CF total ion chromatogram (TIC) which shows the entire ion response obtained from the saliva extract. Three DF/CF conditions were selected where HX and XA are transmitted by the FAIMS along with the internal standard 1-MX d3 : CF 0.7 Td at DF 220 Td (Fig. 3 (b) ), CF 0.9 Td at DF 230 Td (Fig. 3 (c) ), and CF 1.1 Td at DF 240 Td (Fig. 3 (d) ).
The three FAIMS conditions selected were applied to the LC-FAIMS-MS analysis of an unspiked saliva extract in order to determine the optimum DF/CF combination for the transmission of HX, XA and 1-MX d3 . EICs for HX (m/z 137.0458 ± 0.02, 0.91 min) and XA (m/z 153.0407 ± 0.02, 0.96 min) are shown in Fig. 4 . Each of the three FAIMS conditions resulted in a reduction of the co-eluting interferences in the EICs for HX (Fig. 4 (b) to (d)) and XA (Fig. 4 (f) to (h)) compared to LC-MS (Fig. 4 (a) and (e)). The S:N ratio of both HX and XA was increased in comparison to LC-MS for all three FAIMS conditions by an average of 230% for HX and 255% for XA. CF 1.1 Td at DF 240 Td resulted in the largest reduction of coeluting matrix interferences, but also had the largest reduction in the peak intensity at the highest DF. CF 0.7 Td at DF 220 Td had the highest peak intensity, but the least reduction in the coeluting matrix interferences. CF 0.9 Td at DF 230 Td was therefore selected as the FAIMS condition for the analysis as a compromise between peak intensity and separation of coeluting matrix interferences.
The LC-MS chromatographic method was developed to minimise the run time for HX and XA, but this resulted in a significant overlap of the HX peak with salivary matrix components. The observed co-elution of HX with matrix components could be reduced by changing the chromatographic gradient to separate the metabolite from the saliva matrix, at the cost of increased chromatographic run time. Options to improve the selectivity of HX without increasing chromatographic run time include the selection of a narrower mass extraction window using HRMS or the application of FAIMS separation combined with LC-MS [30] . A direct comparison of both techniques to improve selectivity for HX without increasing the run time is shown in Fig. 5 
. The LC-MS and LC-FAIMS-MS EICs for the [HX + H]
+ ion (m/z 137.0458) for the analysis of HX in an unspiked pooled saliva sample, with a high resolution mass window of m/z 137.0458 ± 0.02 is shown in Fig. 5 (a) . The absolute intensity of the HX peak, with FAIMS switched off, is reduced by a factor of two if the mass extraction window is narrowed from ±0.02 (Fig. 5 (a) ) to m/z 137.0458 ± 0.008 (Fig. 5 (b) ), but there is no further discrimination against the co-eluting saliva matrix interference. In contrast, the application of FAIMS separation shows a significant reduction in the co-eluting chemical noise from the saliva matrix (Fig. 5 (c) and (d) ) whilst maintaining the rapid elution time. The removal of chemical noise from the saliva matrix resulted in improved peak integration and S:N even though the absolute intensity of the HX peak was reduced due to ion losses in the FAIMS device. Comparison of the two mass extraction windows with FAIMS on, m/z 137.0458 ± 0.02 (Fig. 5 (c) ) and m/z 137.0458 ± 0.008 ( Fig.  5 (d) ), resulted in a reduction of sensitivity without a significant increase in S:N. Therefore, the ±0.02 mass extraction window was selected for subsequent LC-FAIMS-MS analyses. The mass spectrum from the HX peak with the FAIMS off showed HX with a mass error of −9.6 ppm (m/z 137.0471). Whereas with FAIMS applied (LC-FAIMS-MS) the observed mass error was −0.82 ppm (m/z 137.0459), as a result of discrimination against isobaric co-eluting saliva matrix interferences. Table 1 compares the quantitative performance of the LC-MS and LC-FAIMS-MS methods for the determination of HX and XA using standard additions spiked into a pooled saliva sample. From Table 1 , the limit of detection (LOD; S:N 3:1)) for HX was reduced from 3.8 ng mL −1 (FAIMS off) to 2.0 ng mL −1 (FAIMS on), and the limit of quantification (LOQ; S:N 10:1) was also reduced from 12.6 ng mL −1
(FAIMS off) to 6.6 ng mL −1 (FAIMS on), based on the extracted ion peak areas of HX (m/z 137.0458 ± 0.02) using LC-FAIMS-MS. The LOD and LOQ for XA were similar at 1.9 ng mL −1 and 6.2 ng mL −1 (FAIMS off) and 1.8 ng mL The intra-day reproducibility of the LC-FAIMS-MS system was compared with LC-MS by analysing HX and XA spiked into saliva (100 ng mL
, Table 1 ) in both FAIMS on and FAIMS off modes. Relative standard deviations (%) sufficient for good quantitation were obtained with both LC-MS and LC-FAIMS-MS (1.7% -6.6%). These data for HX demonstrate the FAIMS device can enhance quantitative performance compared to high resolution LC-MS.
LC-FAIMS-MS determination of salivary hypoxanthine and xanthine pre-and post-oxidative stress
The LC-FAIMS-MS method developed for the analysis of HX and XA was applied to the analysis of saliva samples collected from cyclists pre-exercise, immediately post-exercise, onehour post exercise and twenty-four hours post exercise. A large biological variance between participants was observed in the pre-exercise saliva samples with concentrations in the range 3.1-242.9 ng mL −1 (0.02-1.8 uM) for HX and 22.4 to 1183.1 ng mL −1 (0.15-7.8 uM) for XA (Supplementary Table   1 and Supplementary Table 2 ). These XA and HX concentrations are within the ranges previously reported in saliva, although at the lower end of the range for HX [1, 2, 21] . Figure 6 shows box and whisker plots of HX and XA concentrations for male participants pre-and post-exercise. Despite the biological variance in the salivary HX and XA levels pre-exercise, the same overall trend towards lower concentrations immediately after exercise and for the next hour post-exercise is observed, with the levels of HX and XA returning to approximately pre-exercise levels in the twenty-four hours postexercise samples. The observation of lower HX and XA levels in saliva after the physical exercise (Fig. 6 ) is the opposite of the trend previously reported for plasma concentrations of HX, which increased immediately post-exhaustive physical exercise [18, 32] . Lower levels of HX and XA (Fig. 6 ) may be due to changes in enzymatic activity in saliva after exercise [22, 35] . However, significant inter-day variations in salivary levels of HX and XA (and UA) have been reported by Kochańska et al., which may explain the variations in HX and XA concentrations observed in this study. Markelj et al. [21, 26] reported the analysis of saliva and urine by LC-MS, which showed that concentrations of HX and XA were significantly lower, relative to the concentration of UA, in saliva than in urine, although salivary UA has been shown to have a linear correlation with serum UA Fig . 6 Box and whisker plots for male participants (n = 11), of the detected peak areas divided by the internal standard (IS; 1-MX d3 ) peak area for (a) HX and (b) XA at four sampling time points: pre-exercise (Pre), immediately post-exercise (Post), one-hour post-exercise (1-h Post) and twenty-four hours' post-exercise concentrations [31] . Further work is required to understand the relative levels of HX, XA and UA in saliva as a result of oxidative stress.
Conclusion
A rapid (7 min) method combining miniaturised FAIMS with LC-MS and non-invasive sampling has been developed for the determination of HX and XA in saliva. Using LC-FAIMS-MS, improved chromatographic peak integration was possible, in comparison to LC-MS, due to the reduction in the co-eluting chemical interferences from the saliva matrix. This also resulted in improved mass spectrometric observed mass error using HRMS, aiding in the qualitative identification and quantitation of the purine based derivatives, HX and XA. Saliva samples analysed from healthy male athletes showed a decrease in salivary oxypurines immediately postexercise and one-hour post-exercise, in comparison to levels determined pre-exercise and twenty-four hours' post-exercise, which suggests that both HX and XA could be used as biomarkers of oxidative stress. The combination of LC-FAIMS-MS with the non-invasive sampling collection technique for saliva has potential as a rapid and high-throughput screening technique for oxidative stress, based on the determination of oxypurine metabolite biomarkers, as well as in other clinical applications.
